NCT01485900View on ClinicalTrials.gov

Repeated Dosing Study to Assess Safety and Tolerability in CKD-3 Patients on Stable ACE-I Treatment

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions
Chronic Kidney Disease
Interventions
DRUG

SAR407899A

"Pharmaceutical form:capsule~Route of administration: oral"

Trial Locations (2)

2025

Investigational Site Number 498002, Chisinau

Unknown

Investigational Site Number 642001, Bucharest

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY